Cases 31 - 40 of 127
BAYER INTELLECTUAL PROPERTY GMBH et al v. USV PRIVATE LIMITED
as 2:2022cv05485
Plaintiff:
BAYER INTELLECTUAL PROPERTY GMBH, BAYER PHARMA AG, BAYER AG and others
Defendant:
USV PRIVATE LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
BAYER INTELLECTUAL PROPERTY GMBH et al v. USV PRIVATE LIMITED
as 3:2022cv05485
Plaintiff:
BAYER INTELLECTUAL PROPERTY GMBH, BAYER PHARMA AG, BAYER AG and others
Defendant:
USV PRIVATE LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
BAYER INTELLECTUAL PROPERTY GMBH et al v. CHANGZHOU PHARMACEUTICAL FACTORY
as 2:2022cv02089
Plaintiff:
BAYER INTELLECTUAL PROPERTY GMBH, BAYER AG and JANSSEN PHARMACEUTICALS, INC.
Defendant:
CHANGZHOU PHARMACEUTICAL FACTORY
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. ACCORD HEALTHCARE, INC.
as 2:2022cv00856
Plaintiff:
JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant:
ACCORD HEALTHCARE, INC., ACCORD HEALTHCARE, LTD. and INTAS PHARMACEUTICALS, LTD.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Bayer Pharma AG et al v. Micro Labs Ltd. et al
as 1:2022cv00165
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Counter Claimant:
Micro Labs Ltd. and Micro Labs USA Inc.
Cause Of Action: 35 U.S.C. § 271
Janssen Pharmaceuticals, Inc., et al. v. Tolmar, Inc.
as 1:2021cv01784
Counter Defendant:
Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica NV
Counter Claimant:
Tolmar, Inc.
Defendant:
Tolmar Therapeutics, Inc., Tolmar Pharmaceuticals, Inc. and Tolmar Holding, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Mylan Pharmaceuticals Inc. et al
as 1:2021cv01742
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 3:2021cv18609
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, L.L.C.
Defendant:
MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 35 U.S.C. § 145
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED
as 3:2021cv15137
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, LLC
Defendant:
MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
